A nonrandom association of sarcoidosis in patients with gastrointestinal stromal tumor and other sarcomas

Andrea P. Espejo, Jeremy L. Ramdial, Breelyn A Wilky, Darcy Kerr, Jonathan Trent

Research output: Contribution to journalArticle

Abstract

In patients with sarcoma, concomitant malignancy is found in 1.2% -2.5% of cases. Previous studies have demonstrated conflicting results in terms of positive or negative effects on cancer prognosis with comorbid sarcoidosis. Additionally, there are no data determining whether an association between sarcoidosis and sarcomas exists. Finding an association between the two entities could prevent inadvertent upstaging of a primary sarcoma based on pulmonary nodularity mistaken for metastatic disease. Here, we will describe eight sarcoma patients with concomitant occurrence of sarcoidosis identified since 2007. Eight patients with diagnosis of both sarcoma and sarcoidosis were identified over the period of 2007 -2016 at a single sarcoma center. Clinical and historical data including presentation, histology, treatment, and outcome was tabulated for analysis. The standardized incidence ratio was calculated for the state of Florida and our hospital catchment area. We compared the observed incidence to the expected incidence if the two entities were to be unrelated. Sarcoma subtype was gastrointestinal stromal tumor in five patients, the remaining three cases were unclassified spindled and epithelioid cell sarcoma, uterine leiomyosarcoma, and myxofibrosarcoma. Sarcoidosis was diagnosed before sarcoma in three patients, after sarcoma in four patients, and at the same time of sarcoma diagnosis in one patient. From our series, three patients have shown no progression of sarcoma, two are alive with sarcoma, two died due to progression of sarcoma, and one was lost to follow up. Statistical analyses showed a standardized incidence ratio of 305 (95% confidence interval: 131 -556) for the state of Florida and standardized incidence ratio of 950 (95% CI: 407 -1727) for our catchment area. This case series points to a statistically robust, nonrandom association between sarcoma and sarcoidosis that has not been previously described. Presumed metastatic sarcoma should be considered for biopsy particularly with demographic characteristics or imaging features suggestive of sarcoidosis.

Original languageEnglish (US)
JournalRare Tumors
Volume10
DOIs
StatePublished - Jul 17 2018

Fingerprint

Gastrointestinal Stromal Tumors
Sarcoidosis
Sarcoma
Incidence
Epithelioid Cells
Leiomyosarcoma
Lost to Follow-Up

Keywords

  • gastrointestinal stromal tumor
  • metastatic sarcoma
  • sarcoidosis
  • Sarcoma
  • soft tissue sarcoma

ASJC Scopus subject areas

  • Histology
  • Oncology

Cite this

A nonrandom association of sarcoidosis in patients with gastrointestinal stromal tumor and other sarcomas. / Espejo, Andrea P.; Ramdial, Jeremy L.; Wilky, Breelyn A; Kerr, Darcy; Trent, Jonathan.

In: Rare Tumors, Vol. 10, 17.07.2018.

Research output: Contribution to journalArticle

@article{9b544454c4164048addf6d6d1a82b47d,
title = "A nonrandom association of sarcoidosis in patients with gastrointestinal stromal tumor and other sarcomas",
abstract = "In patients with sarcoma, concomitant malignancy is found in 1.2{\%} -2.5{\%} of cases. Previous studies have demonstrated conflicting results in terms of positive or negative effects on cancer prognosis with comorbid sarcoidosis. Additionally, there are no data determining whether an association between sarcoidosis and sarcomas exists. Finding an association between the two entities could prevent inadvertent upstaging of a primary sarcoma based on pulmonary nodularity mistaken for metastatic disease. Here, we will describe eight sarcoma patients with concomitant occurrence of sarcoidosis identified since 2007. Eight patients with diagnosis of both sarcoma and sarcoidosis were identified over the period of 2007 -2016 at a single sarcoma center. Clinical and historical data including presentation, histology, treatment, and outcome was tabulated for analysis. The standardized incidence ratio was calculated for the state of Florida and our hospital catchment area. We compared the observed incidence to the expected incidence if the two entities were to be unrelated. Sarcoma subtype was gastrointestinal stromal tumor in five patients, the remaining three cases were unclassified spindled and epithelioid cell sarcoma, uterine leiomyosarcoma, and myxofibrosarcoma. Sarcoidosis was diagnosed before sarcoma in three patients, after sarcoma in four patients, and at the same time of sarcoma diagnosis in one patient. From our series, three patients have shown no progression of sarcoma, two are alive with sarcoma, two died due to progression of sarcoma, and one was lost to follow up. Statistical analyses showed a standardized incidence ratio of 305 (95{\%} confidence interval: 131 -556) for the state of Florida and standardized incidence ratio of 950 (95{\%} CI: 407 -1727) for our catchment area. This case series points to a statistically robust, nonrandom association between sarcoma and sarcoidosis that has not been previously described. Presumed metastatic sarcoma should be considered for biopsy particularly with demographic characteristics or imaging features suggestive of sarcoidosis.",
keywords = "gastrointestinal stromal tumor, metastatic sarcoma, sarcoidosis, Sarcoma, soft tissue sarcoma",
author = "Espejo, {Andrea P.} and Ramdial, {Jeremy L.} and Wilky, {Breelyn A} and Darcy Kerr and Jonathan Trent",
year = "2018",
month = "7",
day = "17",
doi = "10.1177/2036361318787626",
language = "English (US)",
volume = "10",
journal = "Rare Tumors",
issn = "2036-3605",
publisher = "PagePress",

}

TY - JOUR

T1 - A nonrandom association of sarcoidosis in patients with gastrointestinal stromal tumor and other sarcomas

AU - Espejo, Andrea P.

AU - Ramdial, Jeremy L.

AU - Wilky, Breelyn A

AU - Kerr, Darcy

AU - Trent, Jonathan

PY - 2018/7/17

Y1 - 2018/7/17

N2 - In patients with sarcoma, concomitant malignancy is found in 1.2% -2.5% of cases. Previous studies have demonstrated conflicting results in terms of positive or negative effects on cancer prognosis with comorbid sarcoidosis. Additionally, there are no data determining whether an association between sarcoidosis and sarcomas exists. Finding an association between the two entities could prevent inadvertent upstaging of a primary sarcoma based on pulmonary nodularity mistaken for metastatic disease. Here, we will describe eight sarcoma patients with concomitant occurrence of sarcoidosis identified since 2007. Eight patients with diagnosis of both sarcoma and sarcoidosis were identified over the period of 2007 -2016 at a single sarcoma center. Clinical and historical data including presentation, histology, treatment, and outcome was tabulated for analysis. The standardized incidence ratio was calculated for the state of Florida and our hospital catchment area. We compared the observed incidence to the expected incidence if the two entities were to be unrelated. Sarcoma subtype was gastrointestinal stromal tumor in five patients, the remaining three cases were unclassified spindled and epithelioid cell sarcoma, uterine leiomyosarcoma, and myxofibrosarcoma. Sarcoidosis was diagnosed before sarcoma in three patients, after sarcoma in four patients, and at the same time of sarcoma diagnosis in one patient. From our series, three patients have shown no progression of sarcoma, two are alive with sarcoma, two died due to progression of sarcoma, and one was lost to follow up. Statistical analyses showed a standardized incidence ratio of 305 (95% confidence interval: 131 -556) for the state of Florida and standardized incidence ratio of 950 (95% CI: 407 -1727) for our catchment area. This case series points to a statistically robust, nonrandom association between sarcoma and sarcoidosis that has not been previously described. Presumed metastatic sarcoma should be considered for biopsy particularly with demographic characteristics or imaging features suggestive of sarcoidosis.

AB - In patients with sarcoma, concomitant malignancy is found in 1.2% -2.5% of cases. Previous studies have demonstrated conflicting results in terms of positive or negative effects on cancer prognosis with comorbid sarcoidosis. Additionally, there are no data determining whether an association between sarcoidosis and sarcomas exists. Finding an association between the two entities could prevent inadvertent upstaging of a primary sarcoma based on pulmonary nodularity mistaken for metastatic disease. Here, we will describe eight sarcoma patients with concomitant occurrence of sarcoidosis identified since 2007. Eight patients with diagnosis of both sarcoma and sarcoidosis were identified over the period of 2007 -2016 at a single sarcoma center. Clinical and historical data including presentation, histology, treatment, and outcome was tabulated for analysis. The standardized incidence ratio was calculated for the state of Florida and our hospital catchment area. We compared the observed incidence to the expected incidence if the two entities were to be unrelated. Sarcoma subtype was gastrointestinal stromal tumor in five patients, the remaining three cases were unclassified spindled and epithelioid cell sarcoma, uterine leiomyosarcoma, and myxofibrosarcoma. Sarcoidosis was diagnosed before sarcoma in three patients, after sarcoma in four patients, and at the same time of sarcoma diagnosis in one patient. From our series, three patients have shown no progression of sarcoma, two are alive with sarcoma, two died due to progression of sarcoma, and one was lost to follow up. Statistical analyses showed a standardized incidence ratio of 305 (95% confidence interval: 131 -556) for the state of Florida and standardized incidence ratio of 950 (95% CI: 407 -1727) for our catchment area. This case series points to a statistically robust, nonrandom association between sarcoma and sarcoidosis that has not been previously described. Presumed metastatic sarcoma should be considered for biopsy particularly with demographic characteristics or imaging features suggestive of sarcoidosis.

KW - gastrointestinal stromal tumor

KW - metastatic sarcoma

KW - sarcoidosis

KW - Sarcoma

KW - soft tissue sarcoma

UR - http://www.scopus.com/inward/record.url?scp=85054585241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054585241&partnerID=8YFLogxK

U2 - 10.1177/2036361318787626

DO - 10.1177/2036361318787626

M3 - Article

AN - SCOPUS:85054585241

VL - 10

JO - Rare Tumors

JF - Rare Tumors

SN - 2036-3605

ER -